modified citrus pectin for inflammation
Modified Citrus Pectin (MCP), also known as Low Molecular Citrus Pectin (LCP), is a small-molecule, water-soluble fiber polysaccharide rich in galactose. It is extracted from the peels and pulp of citrus fruits (such as lemons, oranges, tangerines, and grapefruits) using advanced bio-enzymatic technology. As one of only two global producers and the sole manufacturer in Asia, Gold Kropn Biotechnology Co., Ltd. has collaborated with leading research institutions such as Zhejiang University and Fudan University, obtaining multiple national invention patents to ensure the product's high quality and exceptional efficacy.
Mechanisms of MCP In Promoting inflammation
Modified Citrus Pectin for Inflammation: A Breakthrough in Joint Health
Research Collaboration by Guoyuankangpin Biotechnology Co., Ltd. and Peking Union Medical College Hospital
Galectin-3 (Gal-3), a key pro-inflammatory factor in joint cartilage damage and osteoarthritis progression, has emerged as a promising therapeutic target. Modified citrus pectin (MCP), a natural Gal-3 inhibitor with excellent biocompatibility, shows strong anti-inflammatory potential-but its effects on cartilage cell inflammation were previously unclear.

Key Findings on Modified Citrus Pectin and Inflammation
Reduces Pro-Inflammatory Markers: Modified citrus pectin significantly decreases the expression of Gal-3 and MMP-13 (a cartilage-degrading enzyme), both critical drivers of inflammation and joint deterioration.
Counters IL-1β-Induced Inflammation: In an IL-1β-triggered inflammation model, MCP reversed cartilage breakdown by:
Restoring protective components: Boosting collagen type II, aggrecan, and SOX9.
Blocking damage signals: Suppressing Gal-3, MMP-13, and collagen type I.
Promotes Healthy Cartilage Cells: At 250–750 mg/L concentrations, modified citrus pectin enhanced cartilage cell growth while preventing abnormal cell changes.
This study confirms that modified citrus pectin combats inflammation by neutralizing Gal-3 and balancing cartilage metabolism-offering a novel, science-backed approach to osteoarthritis management.
Product Highlight:
Formulated with premium modified citrus pectin, our supplement harnesses this research to support joint comfort and mobility. Ideal for inflammation-related joint concerns.
Research Partners:
Gold Kropn Biotechnology Co., Ltd. (MCP material provider)
Institute of Biomedical Engineering, Chinese Academy of Medical Sciences (Study design & analysis)
Conclusion: By targeting Gal-3 and key inflammatory pathways, modified citrus pectin delivers dual action-fighting inflammation while protecting cartilage. A natural solution for joint health, validated by cutting-edge science.
Summary
MCP's unique properties-such as water retention, gel formation, film formation, chelation, microbial degradation, and modified citrus pectin inflammation reduction-make it a powerful and natural solution for maintaining gastrointestinal health. By regulating bowel movements, protecting the intestinal lining, promoting beneficial gut bacteria, and reducing inflammation, MCP supports overall digestive wellness and enhances skin health. Its modified citrus pectin inflammation-modulating effects further highlight its potential as a therapeutic agent for inflammatory conditions.
Recommended Daily Intake
Take 1.5-3 grams per day, preferably before meals, to experience the full range of MCP's detoxifying, beautifying, and health-promoting benefits.
Payments And Packaging
Payment Methods: T/T;
Storage: Keep in a cool, dry, and clean place, Protect from moisture and direct light.
Bulk Package: 25kg/drum.


Lead Time: 7 Days After Down Payment.
Shelf Life: 2 Years.
Remark: Customized Specifications Can Also Be Achieved.
Delivery Methods for Your References

Hot Tags: modified citrus pectin for inflammation, China modified citrus pectin for inflammation manufacturers, suppliers, factory, pectin powder supplement, citrus pectin mcp, mcp pectin, modified citrus pectin weight loss, modified citrus pectin inflammation, modified citrus pectin lead











